Cochrane Summaries

Trusted evidence. Informed decisions. Better health.
Language:
English

Evidence on beneficial or harmful effects of bicyclol for chronic hepatitis C is not found

Yang X, Zhuo Q, Wu T, Liu GJ
Published Online: 
21 January 2009

Bicyclol is a novel synthetic 'anti-hepatitis' drug, used primarily in China for patients with chronic hepatitis C. Only one small, short-term randomised clinical trial was found evaluating the efficacy of bicyclol for patients with chronic hepatitis C. Clinicians should be aware of the lack of evidence for bicyclol.